Open access
2026
Combined Inhibition of EZH2 and HMGA1 Affects Gastric Carcinoma Cell Viability
The potential clinical application of ET-743 and GSK126 as standalone agents or in combination with standard chemotherapy for gastric cancer treatment is supported, and their pharmacological inhibition exerts potent, complementary antitumor effects while sparing normal gastric cells.
M. De Martino, V. Franco, Simona Pellecchia et al.
· Oncology Research · 0 citations